✦ LIBER ✦

Bioavailability and disposition of terodiline in man

✍ Scribed by B. Hallén; M. O. Karlsson; S. Stromberg; B. Norén

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 761 KB
Volume: 83
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600830911

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition and bioavailability of the β

Disposition and bioavailability of the β1-adrenoceptor antagonist talinolol in man

✍ Dr. Beate Trausch; R. Oertel; K. Richter; T. Gramatté 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

In an open randomized crossover study, the pharmacokinetics and bioavailability of the selective P1-adrenoceptor antagonist talinolol (CordanumB -Arzneimittelwerk Dresden GmbH, Germany) were investigated in twelve healthy volunteers (five female, seven male; three poor and nine extensive metabolizer

Disposition and absolute bioavailability

Disposition and absolute bioavailability of furosemide in healthy males

✍ Elaine S. Waller; Stephen F. Hamilton; Joseph W. Massarella; Motria A. Sharanevy 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Bioavailability of terfenadine in man

✍ R. A. Okerholm; D. L. Weiner; R. H. Hook; B. J. Walker; G. A. Leeson; S. A. Bied 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 1 views

## Abstract Fourteen normal male subjects were given either 60 mg or 180mg of terfenadine suspension in a randomized two‐way crossover study. Peak plasma concentrations of 1.544 ± 0.726 (mean ± S.D.) ng ml^−1^ were obtained in 0.786 ± 0.426 h following the 60 mg dose and displayed an AUC of 11.864

Bioavailability of medroxalol in man

✍ Frederick J. Keeley; Daniel L. Weiner; Richard A. Okerholm 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 2 views

Ten healthy male volunteers received single oral doses of l00mg of medroxalol administered as a solution, a preliminary tablet formulation and a single dose of lOOmg administered intravenously in a randomized three-way crossover study. Mean terminal half-lives of 12.4, 13.4, and 11.3 h were observed

Bioavailability and disposition kinetics

Bioavailability and disposition kinetics of HI-6 in Beagle dogs

✍ J. D. Baggot; A. Buckpitt; D. Johnson; P. Brennan; H. Chung 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 760 KB

The absorption and disposition kinetics of HI-6 were determined in Beagle dogs given single doses (25 mg kg-') of the drug by the intravenous, intramuscular, and oral routes. Concentrations of the oxime in plasma and urine were measured by HPLC. A twocompartment open model was used to describe the d

Stereoselective disposition of talinolol

Stereoselective disposition of talinolol in man

✍ Michael Zschiesche; Girum Lakew Lemma; Klaus-Jürgen Klebingat; Gerd Franke; Bern 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

The disposition of the b-blocking drug talinolol is controlled by P-glycoprotein in man. Because talinolol is marketed as a racemate, we reevaluated the serum-concentration time pro®les of talinolol of a previously published study with single intravenous (30 mg) and repeated oral talinolol (100 mg f